
Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

